Supplier News
Suni Lee spotted in KISS Salon X-tend Nails at Olympic games
Suni Lee, 2020 Olympic all-around gymnastics champion and brand ambassador for the New KISS Salon X-tend LED Soft Gel System, was spotted competing at the 2024 Olympic games this weekend wearing New KISS Salon X-tend Nails in the style Pure, her favorite go-to look, an almond shaped nail with a Fren
The Hershey’s Store unveils Reese’s Peanut Butter Pumpkins
You may be thinking, “It’s too soon to celebrate Halloween, right?” Well, when there’s Reese’s involved, it’s never too early. The brand is giving chocolate and peanut butter lovers exactly what they deserve with the release of Reese’s Peanut Butter Pumpkins for the first time ever on shop.hersheys.
Sun Pharma receives FDA approval for new alopecia areata treatment
Sun Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) approved LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. Alopecia areata affects around 700,000 people in the United States, and 300,000 have severe alopecia areata.
OCuSOFT introduces OCuSOFT Retaine Allergy Artificial Tears for eye allergy itch relief
OCuSOFT Inc., a privately-held eye and skin care company with an established reputation for innovation in eyelid hygiene announces the availability of OCuSOFT Retaine Allergy original prescription strength antihistamine tears for eye allergy itch relief.
CHPA joins 17 Health Choices Coalition Members to support Oral Health Products Inclusion Act
WASHINGTON – The Consumer Healthcare Products Association (CHPA) today released the following statement after joining 17 other members of the Health Choices Coalition – a group comprised of healthcare providers, patients, consumers, retailers, manufacturers, pharmacies, insurers, and businesses of a
CHPA recognizes International Self-Care Day
WASHINGTON – The Consumer Healthcare Products Association (CHPA), the leading voice advocating to empower self-care by preserving and expanding access to trusted consumer healthcare products, today released the following statement in recognition of International Self-Care Day, which is recognized an
Eosera’s new foundation and $35,000 pitch competition
FORT WORTH, Texas – In a state ranked fifth best for women-owned startups, the Eosera foundation proudly announces its third annual pitch competition, a dynamic platform designed to propel female-led businesses in Texas to new heights.
Aurobindo gets FDA approval for dutasteride and tamsulosin hydrochloride capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for dutasteride and tamsulosin hydrochloride capsules 0.5 mg/0.4 mg.
Aurobindo receives FDA approval for baricitinib tablets
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application baricitinib tablets, 1mg and 2mg.
Registrar Corp. launches Adverse Events Management Software
Registrar Corp, the world’s largest FDA compliance company with 32,000 clients in 190 countries, announced the roll out of Adverse Event Management (AEM) Software. The first-of-its-kind software enables cosmetics companies to comply with the U.S.
Kellanova expands partnership with Interpublic Group
Kellanova has announced the expansion of their partnership with Interpublic Group (IPG). The move advances Kellanova’s Differentiate, Drive and Deliver strategy and the growth ambitions the company has for its stable of iconic brands.
CHPA welcomes 15 new members and celebrates longtime partnerships
Today, the Consumer Healthcare Products Association (CHPA), the national trade association representing the leading manufacturers and marketers of consumer healthcare products, announced the addition of 15 new members, four manufacturers and 11 associate members, from the last quarter.
Aurobindo receives FDA nod for posaconazole delayed-release tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application posaconazole delayed-release tablets 100mg.
Acosta Group’s evolution: an interview with Brian Wynne following Crossmark acquisition
The next chapter in Acosta Group’s ongoing evolution has arrived with the completion of the company’s acquisition of Crossmark and Product Connections.
La Roche-Posay debuts exhibition at Edge
NEW YORK CITY – Edge, the highest indoor/outdoor sky deck in the Western Hemisphere, invites New Yorkers and visitors to “SHADES,” a new immersive installation on display now through September in partnership with worldwide expert in advanced UV protection, La Roche-Posay.